GG 931 (Orphenadrine Citrate Extended-Release 100 mg)
Pill imprint GG 931 has been identified as Orphenadrine citrate extended-release 100 mg.
Orphenadrine is used in the treatment of muscle spasm; migraine and belongs to the drug class skeletal muscle relaxants. Risk cannot be ruled out during pregnancy. Orphenadrine 100 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for GG 931 (Orphenadrine Citrate Extended-Release 100 mg)
Orphenadrine citrate extended-release
- Imprint:
-
GG 931
- Strength:
- 100 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Skeletal muscle relaxants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Actavis
- National Drug Code (NDC):
- 52152-0340
| NDC Code | Manufacturer / Repackager |
|---|---|
| 43386-0480 | Gavis Pharmaceuticals |
| 55045-1325 | Dispensing Solutions Inc. (repackager) |
| 57866-7601 | Direct Dispensing Inc (repackager) |
| 10544-0359 | Blenheim Pharmacal Inc (repackager) |
Note: Inactive ingredients may vary.
More resources
Orphenadrine citrate extended-release is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
